Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
0.2
%
1,71%
Latest
11.9
High
11.9
Low
11.6
Volume
20 831
Turnover (SEK)
244 712
Value (MSEK)
124,5

Board

CEO

  • Maria Alriksson

Chairman Of The Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Fredrik Juserius
  • Joen Luirink

Videos

Largest Owners

Name Capital % Votes % Date
Anders Ericsson 6,66 6,66 2021-02-08
Anders Wall Stiftelser 5,87 5,87 2021-02-08
Magnus Lindroth 5,74 5,74 2021-02-24
Jan-Willem De Gier 5,71 5,71 2021-02-08
Joen Luirink 5,58 5,58 2021-02-08
John Moll 4,90 4,90 2021-02-08
Johan Källstrand 4,20 4,20 2021-02-08
Martin Ericsson 3,64 3,64 2021-02-08
Maria Alrikson 2,48 2,48 2021-02-08
Mårten Hellberg 2,28 2,28 2021-02-08
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Upcoming reports

  • 2021-05-12 Delårsrapport 2021-Q1

  • 2021-08-11 Delårsrapport 2021-Q2

  • 2021-11-10 Delårsrapport 2021-Q3